Mutation

views updated

MUTATION

There is ample evidence that mutations are causally related to cancer, a prominent age-related disease. Since the 1950s the accumulation of spontaneous mutations in the DNA of organs and tissues has been hypothesized to underlie aging itself (e.g., Failla, 1958). What are mutations, and why are they there? First, it is necessary to distinguish DNA mutations from DNA damage. DNA damage consists of chemical alterations in DNA structure, leading to a structure that can no longer serve as a substrate for faithful replication or transcription. DNA damage cannot be copied to end up in daughter cells. DNA mutations are heritable changes in a DNA sequence of an organism, which can be part of a gene, a gene regulatory region, or some noncoding part of the genome. Mutations are usually introduced as a consequence of misreplication or misrepair, for example, due to the presence of DNA damage. Hence, DNA damage can lead to mutations when it is not correctly repaired. Mutations can vary from point mutations, involving single or very few base pairs to large deletions, insertions, duplications, and inversions. In organisms with multiple chromosomes, DNA from one chromosome can be joined to another and the actual chromosome number can be affected.

Mutations are inevitable. Indeed, they fuel the survival of cells and organisms in times of stress. They are the substrate for evolution, which gave rise to different life forms. In both prokaryotic and eukaryotic cells mutation rate can be greatly increased, causing many cells to die but also giving rise to cells with the necessary attributes to survive and expand. Cancer cells, for example, can undergo mutations in genes that control the mutation rate (for example, genes involved in DNA repair). Such "mutator phenotypes" allow them to accelerate the acquisition of novel attributes (e.g., drug resistance, tissue invasivity) through gene mutation. While in such cases mutations are detrimental for the host, they are beneficial for the cell. In most cases, mutations will have adverse effects on both the host and the cell. In the somatic cells of multicellular organisms, however, mutations usually have adverse effects.

Gross chromosomal alterations

The earliest and still the most popular way to look at mutations is by cytogenetic means. This necessarily precludes the detection of mutational events smaller than a few million base pairs and also limits the target tissue to cells in metaphase, usually white blood cells. A noteworthy exception to this latter limitation is the original work of the late Howard Curtis (1963), who with coworkers examined mouse liver parenchymal cell metaphase plates after partial hepatectomy and found considerably higher numbers of cells with abnormal chromosomes in old, compared with young, animals (i.e., from about 10 percent of the cells in mice four to five months old to 75 percent in mice older than twelve months). Later, large structural changes in DNA were observed to increase with donor age in white blood cells of human individuals, from about 2–4 percent of the cells having chromosomal aberrations in young individuals to about six times higher in the elderly. The recent use of more advanced methods, such as chromosome painting, have confirmed the increase in cytogenetic damage with age in both human and mouse. In both human and mouse lymphocytes the increase in chromosome aberrations appeared to be exponential.

Mutations detected in selectable marker genes

With the development of tests based on selectable endogenous marker genes, it became possible to assess mutation frequencies at these loci in T-cells from human and animal donors (for a review see Vijg, 2000). Using the hypoxanthine phosphoribosyl transferase (HPRT) locus test, investigators have shown that mutation frequencies at this locus increase with donor age. For example, results obtained with this assay suggest that mutation frequencies in humans increase with age from about 2 × 10-6 in young individuals to about 1 x 10-5 in middle aged and old individuals. In mice mutation frequencies have been reported from about 5 x 10-6 in young animals to about 3 x 10-5 in middle aged mice (Dempsey et al., 1993). However, in both mice and humans these values could be underestimates, due to the loss of HPRT mutants in vivo or in vitro. Indeed, results from Grist et al. (1992), who assayed the HLA locus (using immunoselection for mutationally lost HLA antigen) in human lymphocytes, indicate mutant frequencies two to three times higher. Values higher than HPRT were also found with other assays involving selectable target genes. The discrepancy has been explained in terms of the inability of the HPRT test to detect mitotic recombination events (HPRT is X-linked) and a relatively strong in vivo selection against mutants.

In mice subjected to caloric restriction, the only intervention demonstrated to increase life span (Masoro, 1993), HPRT mutation frequencies were found to increase with age at a significantly slower rate than in the animals that fed at will. Dempsey et al. (1993) studied both types of animals for twelve months. They saw an age-associated accumulation of mutations in the mice that fed at will, but not in the mice that experienced calorie restriction. Their conclusion was that the great majority of endogenous mutations are related to diet. However, it is not clear if this effect of diet is the result of intake of multiple exogenous mutagens or is related to the metabolism of food.

The results of Dempsey et al. suggest that the level of accumulated somatic mutations reflects biological rather than chronological age. This conclusion was further strengthened by Odagiri et al. (1998), who demonstrated accelerated accumulation of mutations in peripheral blood lymphocytes of so-called senescence-accelerated mice (SAM). Although the SAM model is not generally accepted as a mouse model of accelerated aging, these findings nevertheless demonstrate a link between somatic mutation rate and physiological decline. Interestingly, the HPRT test has been used on tubular epithelial cells of kidney tissue from human donors two to ninety-four years old. The mutation frequencies found were much higher than the values for blood lymphocytes and also increased with age (Martin et al., 1996). The high mutation frequency in the kidney cells could reflect a relatively slow turnover as compared to T-cells.

Mutations in transgenic mouse reporter genes

With the development of transgenic mouse models harboring chromosomally integrated reporter genes, it became possible to directly test the hypothesis that somatic mutations in a neutral (with no function) gene accumulate with age in various organs and tissues (Gossen and Vijg, 1993). Using one of these models, harboring the lacI gene as a target, Lee et al. (1994) were the first to demonstrate an age-related increase in mutation frequency in spleen from about 3 × 10-5 in mice of a few weeks old to 1-2 × 10-4 in 24-month-old animals. Subsequent results from other laboratories indicated age-related increases in mutation frequency in some, but not all, organs. Dollé et al. (1997), for example, demonstrated that mutation frequencies at a lacZ transgene increase with age in the liver, while such an increase was virtually absent in the brain. The increased susceptibility to spontaneous mutagenesis of liver versus brain corresponds to observed higher frequency of focal pathological lesions in the mouse liver as compared with the brain (Bronson, 1990). More recently, the pattern of organ specificity in age-related mutation accumulation was expanded with the observation of age-related increases in mutation frequencies in spleen, heart, and small intestine, but not in testes (Dollé et al., 2000).

Essentially the same results obtained by Dollé et al. (1997) were found by Ono et al. (2000). These investigators used the original mouse model of Gossen et al. (1989), harboring the same transgene. They also observed an age-related increase of mutation frequency in the liver, heart, and spleen, but virtually no increase in the brain and testes. Dollé et al. (1997; 2000) also observed striking organ specificity with respect to the mutational spectra of the old animals. While in the small intestine and the brain virtually only point mutations accumulated (the small increase in the brain was almost totally due to point mutations), in the liver and especially in the heart large deletion mutations were a prominent part of the spectrum (Dollé et al., 1997).

In interpreting these data it should be noted that the observed increases were modest (varying from less than twofold, to more than fourfold) and appeared to level off at middle age (Lee et al., 1994; Dollé et al., 1997). The relatively small age-related increase of mutant frequencies can be interpreted as evidence against a major role for somatic mutations in aging (Warner and Johnson, 1997). However, although transgenic reporter genes do not suffer from a selection bias (as is the case with most selectable endogenous targets), it still provides an underestimate of the real mutation load and its adverse effects. Homologous (mitotic) recombination, for example, leading to deletion of entire reporter gene copies is a frequent mutational event and goes undetected in the transgenic assays. Most of the transgenic models also do not account for mutational hot spots, and such important functional end points as cell death are missed. Indeed, to put the results on mutant frequencies of different organs and tissues at various age levels into context, it will be necessary also to assess cell proliferation and cell death. Most important, it will be necessary to determine at some point the critical level of cellular mutation loads in terms of physiological consequences. The question is whether the mutation loads observed in a tissue at old age have physiological consequences. A glimpse of an answer can possibly be obtained from another type of model system.

Models for genome instability

Evidence that mutation accumulation does play a role in the functional decline and increased incidence of disease associated with aging can be derived from the work with mouse models having genetically engineered defects in genome stability systems. For example, cells in highly proliferating organs of telomerase-null mice (knockout or defective mice) showed erosion of telomeres, resulting in high levels of genetic instability (fusion and loss of chromosomes), accompanied by increased programmed cell death and a compromised capacity for cell renewal in spleen and bone marrow. In a subsequent study of third-generation telomerase-null mice, shortened life span was found to be accompanied by reduced capacity to respond to stresses, such as wound healing, and by an increased incidence of spontaneous malignancies (Rudolph et al., 1999). The results of these studies underscore that in proliferative organs (highly proliferating cells in organs of telomerase defective mice) the early initiation of genetic instability due to telomere erosion can greatly accelerate age-related loss of cell viability and increased tumor formation.

Other examples of genome stability mutants that point to accelerated aging are mouse models with inactivated genes involved in double-strand break repair. These animals prematurely exhibit symptoms of age-related degeneration in liver, skin, and bone (Vogel et al., 1999). Hence, it appears that genetic defects promoting genomic rearrangements are associated with symptoms of accelerated aging (for a review see Vijg, 2000). This would be in keeping with the results of studies involving patients with Werner syndrome. This genetic disease, caused by a heritable mutation in a single gene (the WRN gene), is characterized by the accelerated occurrence of certain aspects of the senescent phenotype, including cancer. The WRN gene contains both a helicase and an exonuclease function and is thought to play a role in suppressing genomic instability. Indeed, cultured somatic cells from patients with Werner syndrome display an increased rate of somatic mutations and a variety of cytogenetic abnormalities, such as deletions and translocations (Fukuchi et al., 1989). This high level of genomic instability could be the cause of the severe limitation of in vitro life span demonstrated in these cells. Other so-called progeroid syndromes, such ataxia telangiectasia and Bloom syndrome show increased genomic instability (for a review, see Turker and Martin, 1999).

Summary and future prospects

In summary, there is now conclusive evidence that mutations accumulate with age in most organs and tissues of the mouse and in white blood cells of mice and humans. A considerable fraction of this loss of stability of the nuclear genome consists of genome rearrangements. Genome rearrangements in the form of illegitimate recombinations are likely to be due to misrepair and misannealing of double-strand breaks or other DNA lesions opposite one another on the two DNA strands. In view of the elevated occurrence of this type of mutation in white blood cells of patients with segmental progeroid syndromes, it is tempting to speculate that if mutations contribute to the adverse effects associated with aging, genome rearrangements play a major role. Indeed, it is unlikely that randomly induced point mutations will have a major effect on cell functioning. Cellular systems are robust, and insensitive to many mutations. However, sizable genome rearrangements, even a relatively small number, could seriously affect normal regulation, through gene dosage or position effects. A dosage effect is another standard term in biology and means that an additional copy of the gene (or additional copies) will increase the amount of proteins that are produced. (And the other way around, i.e., when one of your two copies of gene X is deleted you may produce less of protein X). In actively proliferating cell compartments one of the predicted effects would be hyperplasia, neoplasia, and tissue atrophy. Hyperplasia is like neoplasia, but a forestage. In many cases (perhaps most) it stays with that and a tumor never results. Atrophy simply means a reduction in mass because of cell loss. In postmitotic cells it could affect a variety of functional pathways leading to a mosaic of cells at different stages and finally to cell death.

Future research in the area of mutation accumulation as a possible cause of aging is likely to focus on two topics. First, more and more emphasis is now given to mouse models genetically manipulated to have defects in genome stability systems. As outlined above, many of these mice also show signs of accelerated aging. By using so-called knock-in models in which natural genes are replaced by genes with subtle alterations rendering them less effective, it should be possible to generate models with overall less effective genome preservation systems without the total absence of one important gene function. If aging is caused by mutation accumulation, it is likely that such mice will mimic the aging phenotype more fully than single-gene knockouts.

Second, a more recent approach, made possible by the completion of the Human Genome Project, is to analyze all genome instability genes for polymorphic variation in different populations of elderly individuals. Gene variants, alone or in combination with others, can then be studied for association with natural differences in life span, functional decline, and age-related disease among elderly persons. Studies of individuals over one hundred years old have provided evidence that genes may play an increasingly prominent role in the ability to achieve older and older age beyond average life expectancy (Perls et al., 1998). It is possible that a combination of optimal genome stability genotypes contributes to the longevity in centenarians.

Jan Vijg

See also Accelerated Aging: Animal Models; Accelerated Aging: Human Progeroid Syndromes; Cellular Aging: Cell Death; Genetics; Longevity: Reproduction; Longevity: Selection; Nutrition: Caloric Restriction; Stress; Theories of Biological Aging.

BIBLIOGRAPHY

Bronson, R. T. "Rate of Occurrence of Lesions in 20 Inbred and Hybrid Genotypes of Rats and Mice Sacrificed at 6 Month Intervals During the First Years of Life." In Genetics of Aging, Vol. 2. Edited by D. E. Harrison. Caldwell, N.J.: Telford Press, 1990. Pages 280–358.

Curtis, H. J. "Biological Mechanisms Underlying the Aging Process." Science 141 (1963): 686–694.

Dempsey, J. L.; Pfeiffer, M.; and Morley, A. A. "Effect of Dietary Restriction on in Vivo Somatic Mutation in Mice." Mutation Research 291 (1993): 141–145.

DollÉ, M. E. T.; Giese, H.; Hopkins, C. L.; Martus, H. J.; Hausdorff, J. M.; and Vijg, J. "Rapid Accumulation of Genome Rearrangements in Liver but not in Brain of Old Mice." Nature Genetics 17 (1997): 431–434.

DollÉ, M. E. T.; Snyder, W. K.; Gossen, J. A.; Lohman, P. H. M.; and Vijg, J. "Distinct Spectra of Somatic Mutations Accumulated with Age in Mouse Heart and Small Intestine." Proceedings of the National Academy of Sciences of the United States of America 97 (2000): 8403–8408.

Failla, G. "The Aging Process and Carcinogenesis." Annals of the New York Academy of Science 71 (1958): 1124–1135.

Fukuchi, K.; Martin, G. M.; and Monnat, R. J., Jr. "Mutator Phenotype of Werner Syndrome is Characterized by Extensive Deletions." Proceedings of the National Academy of Sciences of the United States of America 86 (1989): 5893–5897.

Gossen, J. A.; de Leeuw, W. J. F.; Tan, C. H. T.; Lohman, P. H. M.; Berends, F.; Knook, D. L.; Zwarthoff, E. C., and Vijg, J. "Efficient Rescue of Integrated Shuttle Vectors from Transgenic Mice: A Model for Studying Gene Mutations in Vivo." Proceedings of the National Academy of Sciences of the United States of America 86 (1989): 7971–7975.

Gossen, J. A., and Vijg, J. "Transgenic Mice as Model Systems for Studying Gene Mutations In Vivo." Trends in Genetics 9 (1993): 27–31.

Grist, S. A.; McCarron, M.; Kutlaca, A.; Turner, D. R.; and Morley, A. A. "In Vivo Human Somatic Mutation: Frequency and Spectrum with Age." Mutation Research 266 (1992): 189–196.

Lee, A. T.; DeSimone, C.; Cerami, A.; and Bucala, R. "Comparative Analysis of DNA Mutations in lacI Transgenic Mice with Age." Federation of American Societies for Experimental Biology Journal 8 (1994): 545–550.

Loeb, L. A. "Endogenous Carcinogenesis: Molecular Oncology into the Twenty-First Century—Presidential Address." Cancer Research 49 (1989): 5489–5496.

Martin, G. M.; Ogburn, C. E.; Colgin, L. M.; Gown, A. M.; Edland, S. D., and Monnat, R. J., Jr. "Somatic Mutations are Frequent and Increase with Age in Human Kidney Epithelial Cells." Human Molecular Genetics 5 (1996): 215–221.

Masoro, E. J. "Dietary Restriction and Aging." Journal of the American Geriatrics Society 41 (1993): 994–999.

Odagiri, Y.; Uchida, H.; Hosokawa, M.; Takemoto, K.; Morley, A. A.; and Takeda, T. "Accelerated Accumulation of Somatic Mutations in the Senescence-Accelerated Mouse." Nature Genetics 19, no. 2 (1998): 116–117.

Ono, T.; Ikehata, H.; Nakamura, S.; Saito, Y.; Hosoi, Y.; Takai, Y.; Yamada, S.; Onodera, J.; and Yamamoto, K. "Age-Associated Increase of Spontaneous Mutant Frequency and Molecular Nature of Mutation in Newborn and Old lacZ-Transgenic Mouse." Mutation Research 447 (2000): 165–177.

Perls, T. T.; Bubrick, E.; Wager, C. G.; Vijg, J.; and Kruglyak, L. "Siblings of Centenarians Live Longer." Lancet 351 (1998): 1560.

Rudolph, K. L.; Chang, S.; Lee, H. W.; Blasco, M.; Gottlieb, G. J.; Greider, C.; and DePinho, R. A. "Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice." Cell 96 (1999): 701–712.

Turker, M. S., and Martin, G. M. "Genetics of Human Disease, Longevity and Aging." In Principles of Geriatric Medicine and Gerontology, 4th ed. Edited by W. R. Hazzard, J. P. Blass, W. H. Ettinger, Jr., J. B. Halter, and J. G. Ouslander. New York: McGraw-Hill, 1999.

Vijg J. "Somatic Mutations and Aging: A Re-Evaluation.". Mutation Research 447 (2000): 117–135.

Vogel, H.,; Lim, D. S.; Karsenty, G.; Finegold, M.; and Hasty, P. "Deletion of Ku86 Causes Early Onset of Senescence in Mice." Proceedings of the National Academy of Sciences of the United States of America 96 (1999): 10770–10775.

Warner, H. R., and Johnson, T. E. "Parsing Age, Mutations and Time." Nature Genetics 17 (1997): 368–370.

More From encyclopedia.com